Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)

0
104

Funding Opportunity ID:332475
Opportunity Number:RFA-HG-21-008
Opportunity Title:Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)
Opportunity Category:Discretionary
Opportunity Category Explanation:
Funding Instrument Type:Grant
Category of Funding Activity:Health
Category Explanation:
CFDA Number(s):93.172
Eligible Applicants:Small businesses
Additional Information on Eligibility:Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Agency Code:HHS-NIH11
Agency Name:Department of Health and Human Services
National Institutes of Health
Posted Date:Mar 30, 2021
Close Date:Feb 01, 2023
Last Updated Date:Mar 30, 2021
Award Ceiling:$0
Award Floor:$0
Estimated Total Program Funding:
Expected Number of Awards:
Description:The National Human Genome Research Institute intends to promote a new initiative by publishing a Request for Applications to solicit R43/R44 applications for research in the area of Transformative Nucleic Acid Sequencing Technology Innovation and Early Development: The purpose of the RFA is to refocus and emphasize NHGRIs investment in nucleic acid sequencing technology on novel technology innovation and early development. This Notice is being provided to allow potential applicants sufficient time to develop effective collaborations and responsive projects. The FOA is expected to be published in the winter of 2021 with an expected application due date in the summer of 2021.
Version:1





Visit the Official Webpage For More Details on Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)

LEAVE A REPLY

Please enter your comment!
Please enter your name here